Regeneron Pharmaceuticals (REGN)

Trade REGN now with
3/13/2019 7:01:16 AM Regeneron And Sanofi To Present New Praluent Data At ACC.19
3/8/2019 1:02:12 AM Regeneron And Sanofi : FDA Accept For Priority Review SBLA For Dupixent
3/1/2019 8:37:48 AM Regeneron And Sanofi Say CHMP Recommends Approval Of Dupixent For Asthma Indication
3/1/2019 7:00:34 AM Regeneron, Sanofi To Present Diverse Set Of Clinical And Real-world Data At 2019 AAD Annual Meeting
2/25/2019 5:27:36 PM Regeneron, Sanofi Says Disagree With Verdict Upholding Three Of Five Amgen U.S. Patent Claims On PCSK9 Antibodies
2/6/2019 6:31:32 AM Regeneron Q4 GAAP EPS $7.15; Non-GAAP EPS $6.84
2/4/2019 1:00:37 AM Regeneron: CHMP Recommends Approval Of Praluent (alirocumab) Injection To Reduce Cardiovascular Risk
1/7/2019 2:33:49 AM Regeneron, Sanofi Restructure Immuno-Oncology Collaboration For Discovery And Development Programs
12/1/2018 12:33:54 PM Regeneron Presents Positive Data At ASH For REGN1979 CD20xCD3 Bispecific Antibody In R/R B-Cell Non-Hodgkin Lymphoma
11/12/2018 7:11:21 AM Ziopharm Announces Immuno-oncology Deal With Regeneron To Evaluate Combination Therapy For Patients With Brain Cancer
11/7/2018 5:08:11 PM Sanofi: NEJM Publish Positive Detailed Results Of The 18,924-patient ODYSSEY OUTCOMES Trial